Akesis Pharmaceuticals Inc., of San Diego, named Jay Lichter president and CEO...enGene Inc., of Vancouver, British Columbia, appointed Christopher Rhodes and Imre Kovesdi scientific advisers...Genentech Inc., of South San Francisco, named Leonard Kanavy vice president of commercial operations and Anthony Hurley vice president of fill/finish manufacturing

Access Pharmaceuticals Inc., of Dallas, appointed Jeffrey Davis chairman, and Phillip Wise vice president business development and strategy...commercial operations

and Jeff Silverman vice president, operations integration and new technology development...Thomas Silberg as executive vice president, commercial operations and operational excellence

and David Schenkein vice president, clinical hematology and oncology...and William Kelly vice president, investor relations and corporate communications...Panacos Pharmaceuticals Inc., of Watertown, Mass., appointed Frederick Schmid senior vice president, commercial operations and business development

Ambrilia Biopharma Inc., of Montreal, appointed Joseph Krivulka and Stephen Sudovar to its board...and Charles Montgomery senior vice president, business development and alliance management

Syngenta, of Basel, Switzerland, appointed Carsten Tilger head of communication and public affairs...VaxGen Inc., of Brisbane, Calif., appointed Matthew Pfeffer chief financial officer and senior vice president of finance and administration...Xention Discovery Ltd., of Cambridge, UK, appointed Kenneth Cunningham and Wolfgang Hartwig nonexecutive directors

Wayne Frost vice president, regulatory affairs and quality assurance...MicroIslet Inc., of San Diego, appointed James Gavin interim president and CEO...Pharmacopeia, of Princeton, N.J., said its president and CEO, Leslie Browne, was appointed to the board of trustees of the Biotechnology Council of New Jersey

Ambit Biosciences, of San Diego, appointed Donald Myll senior vice president commercial operations and chief financial officer...American Pharmaceutical Partners Inc., of Schaumburg, Ill., and American BioScience Inc., of Santa Monica, Calif., appointed Carlo Montagner president of Abraxis Oncology...and Jennifer Cook Williams to vice president, investor relations

AdipoGenix Inc., of Boston, appointed Richard Bergman, George Bray and Manuel Navia to its scientific advisory board...ChemGenex Pharmaceuticals Ltd., of Melbourne, Australia, appointed Patrick Burns and Peter Bradfield to its board...Gemin X Biotechnologies Inc., of Montreal, appointed Timothy Barberich and Wayne Roe to its board

and Michael Varney vice president, small-molecule drug discovery...MacroGenics Inc., of Rockville, Md., appointed Nelson Campbell and Ronald Wilder to its senior management team, and promoted Ezio Bonvini to vice president of research, and Joseph Panigot to vice president of legal affairs

Merrimack Pharmaceuticals, of Cambridge, Mass., appointed Dan Littman and James Marks to its scientific advisory board...Nuvelo Inc., of Sunnyvale, Calif., appointed Michael Fleming vice president, commercial operations

It also promoted Robert King to vice president, product development and manufacturing, and Fletcher Payne to vice president, finance...Stressgen Biotechnologies, of San Diego, appointed Gregory McKee president, CEO and director...Tercica Inc., of South San Francisco, appointed Chris Rivera senior vice president, commercial operations, and Thomas Wiggans to its board

Senetek plc, of Napa, Calif., appointed Michael Kloury and Rani Aliahmad to its board...Somaxon Pharmaceuticals Inc., of San Diego, appointed Philip Jochelson senior vice president and chief medical officer...Transkaryotic Therapies Inc., of Cambridge, Mass., appointed Eric Pauwels senior vice president, global commercial operations

MGI Pharma Inc., of Minneapolis, appointed Martin Duvall senior vice president, commercial operations...NeuroNova AB, of Stockholm, Sweden, appointed Ulf Ljungberg president and CEO...OpGen Inc., of Madison, Wis., appointed Joseph Shaw CEO and to its board

Isolagen Inc., of Houston, appointed Dennis Bevan vice president of international commercial operations...Norwood Abbey Ltd., of Melbourne, Australia, appointed Elizabeth Wyatt, Richard Zahn and Ian Hunter to its board

Arena Pharmaceuticals Inc., of San Diego, appointed Harry Hixson and Tina Nova to its board...Biosite Inc., of San Diego, appointed Robin Weiner vice president, regulatory and government affairs...Zonagen Inc., of The Woodlands, Texas, nominated Nola Masterson and David Poorvin to its board

GeneMax Corp., of Vancouver, British Columbia, appointed Terry Pearson and Norman MacKinnon to its board...Genentech Inc., of South San Francisco, promoted Susan Hellmann to president of product development, Myrtle Potter to president of commercial operations and David Ebersman to a member of the executive committee...GTx Inc., of Memphis, Tenn., appointed Andrew Clarkson and Kenneth Glass to its board

Crucell NV, of Leiden, the Netherlands, appointed Ronald Brus president and CEO, replacing Dinko Valerio...ImClone Systems Inc., of New York, appointed William Crouse and David Sidransky to the company's board...It also appointed Clark Springgate vice president of clinical and regulatory

The company also added Giuseppe Dastoli as vice president of business and commercial operations in Europe and Silvia Comis will be responsible for clinical development in Europe